Planning trials in older patients with stroke: Data from the international stroke trial

Age and Ageing

Volumn 40, Issue 3, 2011, Pages 395-398

  Niewada, Maciej ^a   Sandercock, Peter A G ^b   Lindley, Richard I ^c   Członkowska, Anna ^a,d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; FATALITY; FEMALE; GERIATRIC PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PLANNING; PRIORITY JOURNAL; RESEARCH SUBJECT; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED, 80 AND OVER; AGING; BELGIUM; COHORT STUDIES; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; SURVIVAL RATE; SWEDEN; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955421809     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afr030     Document Type: Letter

References (21)

1. Neurology in the elderly: more trials urgently needed. Lancet Neurol 2009; 8: 969.
2. Sanossian N, Ovbiagele B. Prevention and management of stroke in very elderly patients. Lancet Neurol 2009; 8: 1031-41.
3. International Stroke Trial Collaborative Group. The International Stroke Trial a randomized trial of aspirin, subcutaneous heparin, both or neither among 19 435 patients with acute ischemic stroke. Lancet 1997; 349: 1569-81.
4. Zeevi N, Chhabra J, Silverman IE et al. Acute Stroke Management in the Elderly. Cerebrovasc Dis 2007; 23: 304-8.
5. Di Carlo A, Baldereschi M, Gandolfo C et al. Stroke in an elderly population: incidence and impact on survival and daily function. Cerebrovasc Dis 2003; 16: 141-50.
6. Rodgers H, Greenaway J, Davies T et al. Risk factors for firstever stroke in older people in the north east of England: a population-based study. Stroke 2004; 35: 7-11.
7. The ATLANTIS Study: a randomized controlled trial. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 h after symptom onset. JAMA 1999; 282: 2019-26.
8. The European Cooperative Acute Stroke Study. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274: 1017-25.
9. Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-51.
10. Hacke W, Kaste M, Bluhmki E et al. for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 H after acute ischemic stroke. NEJM 2008; 359: 1317-29.
11. Peto R, Baigent C. Trials: the next 50 years. BMJ 1998; 317: 1170-1.
12. Hollander M, Koudstaal PJ, Bots ML et al. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003; 74: 317-21.
13. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997; 28: 2119-25.
14. Wardlaw JM, Zoppo G, Yamaguchi T et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003; 3: CD000213.
15. Sandercock P, Lindley R, Wardlaw J et al. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials 2008; 1: 37.
16. Al Rajeh S. Stroke in the elderly aged 75 years and above. A study from Saudi Arabia. Cerebrovasc Dis 1994; 4: 402-6.
17. Zhu L, Fratiglioni L, Guo Z et al. Association of stroke with dementia, cognitive impairment, and functional disability in the very old, a population-based study. Stroke 1998; 29: 2094-9.
18. Rothwell PM, Coull AJ, Giles MF et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363: 1925-33.
19. Carandang R, Seshadri S, Beiser A et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006; 296: 2939-46.
20. Foerch C, Sitzer M, Steinmetz H et al. for the Arbeitsgruppe Schlaganfall Hessen (ASH). Arbeitsgruppe Schlaganfall Hessen. Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old. Stroke 2009; 40: 1900-2.
21. Toni D. Intravenous thrombolysis with rt-PA in acute stroke patients aged over 80 years. Int J Stroke 2009; 4: 21-2.